胶原酶后的纤维性海绵体炎疾病的治疗（溶组织梭菌胶原酶）

Title:Management of Peyronie's Disease after Collagenase (Xiaflex:^®)

Volume: 16 Issue: 5

Author(s): Amjad Alwaal, Ahmed Aly Hussein, Uwais B. Zaid and Tom F. Lue

Affiliation:

关键词: 药物疗法，纤维性海绵体炎，冲击波疗法，干细胞疗法，胶原酶

摘要: Although the prevalence of Peyronie’s disease (PD) is reported to be 3-9% in men, the true prevalence is likely higher due to under-reporting. Many treatment modalities have been described for PD with varying degrees of success. In this article, we review and summarize the current literature pertaining to all pharmacotherapies (oral, intralesional, iontophoresis, and topical) and minimally invasive treatments available for PD (vacuum, traction device, shock wave therapy, and radiation treatment). Additionally, we discuss emerging therapies for PD that are still in pre-clinical development, including stem cell therapy.

Cite this article as:

Amjad Alwaal, Ahmed Aly Hussein, Uwais B. Zaid and Tom F. Lue , Management of Peyronie's Disease after Collagenase (Xiaflex:^®), Current Drug Targets 2015; 16 (5) . https://dx.doi.org/10.2174/1389450115666141114163128